Skip to main content
. Author manuscript; available in PMC: 2009 Mar 5.
Published in final edited form as: Pediatrics. 2009 Mar;123(3):1037–1044. doi: 10.1542/peds.2008-1162

TABLE 6.

Neuropsychological test results by treatment group (n=327)

INDOMETHACIN Mean (SD)
PLACEBO Mean (SD)
Adjusted Mean Difference* (95% CI)
WISC-III
Verbal IQ 91.9 (18.2) 92.0 (17.6) −1.2 (−4.6, 2.3)
Performance IQ 86.4 (17.5) 88.5 (17.5) −3.2 (−6.8, 0.5)
Full-Scale IQ 88.3 (18.1) 89.4 (17.0) −2.3 (−5.7, 1.2)
LANGUAGE
PPVT-R 93.2 (23.4) 93.2 (24.6) −1.2 (−6.0, 3.6)
CTOPP 92.7 (20.7) 95.4 (20.9) −2.6 (−7.4, 2.3)
CELF – Total language score 85.6 (19.5) 87.1 (19.5) −2.1 (−6.1, 1.9)
TOWRE - Phonemic decoding 91.4 (17.7) 91.9 (16.9) −0.9 (−4.6, 2.9)
TOWRE - Sight word efficiency 93.1 (16.2) 94.8 (15.4) −1.8 (−5.3, 1.7)
Gray Silent Reading Test 89.0 (24.8) 90.3 (24.4) −2.3 (−7.4, 2.9)
*

Adjustment for maternal education, minority, single-parent household Indomethacin-by-gender effect: p-value > 0.05.